Celgene

IDHIFA (enasidenib)

Biodrugs/ Drugs
Blood and Lymphatic systems
Myelodyplastic Syndromes (MDS) RElapsed/refractory IDH2 mutation (US)
4Registration, 3Phase III, 2Phase II, 1Phase I